The activation of BAT and browning of WAT accelerates glycolipid intake, reduces the requirement for insulin secretion, and improves glycolipid metabolism and insulin resistance in patients with obesity and type 2 diabetes [11,12,13]. The gene discussed is INS; the disease is obesity disorder.